Loss of PTEN tumor suppressor enhances metastatic risk in breast cancer, although the underlying mechanisms are poorly defined. We report that homozygous deletion of PTEN in mammary epithelial cells induces tubulin-based microtentacles (McTNs) 
INTRODUCTION
Seeding of solid breast tumors in metastatic sites generally requires release from extracellular matrix (ECM) and periods of suspension in the vasculature or lymphatics. 1 This anchorageindependent survival is a major determinant of tumor dormancy, recurrence and clinical prognosis. [2] [3] [4] Because nearly 90% of human breast tumors are epithelial carcinomas, it is important to study how mammary epithelial cells (MECs) respond to ECM detachment to thoroughly understand metastatic progression and therapeutic opportunities. We have previously shown that MECs extend long dynamic microtubule-based protrusions of the plasma membrane, termed microtentacles (McTNs). McTNs are induced by ECM detachment, structurally distinct from classical actin-based extensions of adherent cells 5 and persist for days in breast tumor lines that are resistant to anoikis. 6, 7 Although traditional studies of tumor dormancy have established the notion that solitary disseminated tumor cells undergo extended periods of inactivity during mitotic quiescence, 8 our findings indicate that detached cells continue to actively respond to the microenvironment via cytoskeletal rearrangement and McTNs without requiring active cell growth.
Metastatic breast tumor cells often display abnormalities in actin cytoskeletal organization compared with their non-tumorigenic counterparts. [9] [10] [11] [12] Normal cells counteract the expansion of microtubules with inward tension from the actin cortex to control cell morphology. However, altering the balance between microtubules and actin has serious implications for circulating tumor cell (CTC) dissemination, as metastatically efficient CTCs can avoid shear-induced fragmentation by undergoing sphereto-cylinder shape transformations within capillaries. 13 PTEN can influence actin organization through dephosphorylation of its lipid substrate phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ) to yield phosphatidylinositol 4,5-bisphosphate (PIP 2 ). Using homologous recombination, we engineered a homozygous deletion in PTEN in MCF-10A human MECs. 14 These PTEN À / À cells have an increase in the PIP 3 :PIP 2 ratio compared with the MCF-10A parental cells, which has been verified by mass spectrometry. 15 Both phosphoinositide lipids are important regulators of the actin cytoskeleton. PIP 2 directly binds actin-associated proteins to tether the actin cytoskeleton to the plasma membrane or activates proteins that are involved in the initiation of de novo actin polymerization (for example, vinculin, profilin and a-actinin).
16-18 PIP 3 can modify guanine nucleotide exchange factors and GTPase-activating proteins, regulators of the Rhofamily GTPases that function as modulators of the actin cytoskeleton. 19 Interestingly, the activities of virtually all actinsevering proteins are downregulated by association with PIP 2 , whereas proteins that promote actin filament nucleation and bundling and membrane coupling are typically activated by PIP 2 . 20 Therefore, the net effect of reduced PIP 2 is actin disassembly.
Cofilin is an actin-severing protein that promotes the dissociation of G-actin from the minus end of F-actin and is activated by dephosphorylation. Cofilin-PIP 2 binding is believed to abrogate the affinity of cofilin for actin. 21, 22 It is possible that the reduced PIP 2 in the PTEN À / À cells could yield more cofilin available to bind actin. By decreasing the ability to counteract PI3K-driven increases in PIP 3 Figure S2) , indicating that the spheroid clusters of PTEN À / À cells arise from cell aggregation rather than division. Time-lapse fluorescence microscopy of live cells expressing membrane-targeted green fluorescent protein (GFP) has illustrated that McTNs promote aggregation by encircling neighboring cells. 7, 25 Mixing PTEN À / À cells differentially labeled with red and green fluorescent membrane probes further demonstrated this cell-wrapping phenomenon with epifluorescence ( Figure 2c ) and confocal microscopy ( Figure 2d ).
Attenuating actomyosin contractility increases McTN production and cell reattachment Current evidence supports a model where the balance between the expansive force of polymerizing microtubules and inward force of the actin cortex regulates McTN protrusion from the cell surface. 25 Accordingly, microtubule stabilization enhances the prevalence of McTNs on detached epithelial cells. 7, 23, 26, 27 McTNs are supported by coordination of the intermediate filament protein, vimentin and stable posttranslational modified forms of a-tubulin (Glu-tubulin). 23 However, neither vimentin nor Glutubulin levels were affected by deletion of PTEN (Supplementary Figure S3) . Therefore, we investigated the potential role of the actin cytoskeleton on McTN formation in response to PTEN deletion. Small-molecule inhibitors were used to examine the role of non-muscle myosin II, which has a fundamental role in cell shape, movement and contractile activity by regulating the actin cytoskeleton. 28 Blebbistatin binds to the myosin-ADP-Pi complex to interfere with phosphate release, thus blocking myosin in a functionally inactive, actin-detached state, paralyzing the motor activity of non-muscle myosin II. 29 The myosin head is unable to contact actin and perform its 'power stroke,' resulting in a weakened actin cortex. The decrease in cellular contractility induced by blebbistatin elevated McTNs three-fold in MCF-10A parental cells and two-fold in PTEN À / À cells (Figure 3a) . The presence of tubulin within the protrusions confirmed their McTN identity ( Figure 3b ). This result suggests that decreasing tension in the actin cortex results in the outward expansion of microtubules during McTN extension. 30 ML-7 is a myosin light chain kinase (MLCK) inhibitor that prevents MLCK from phosphorylating MLC, thus decreasing NMII's ATPase activity and inhibiting contraction. 31 ML-7 was also expected to greatly reduce cortical tension and contractility, thereby increasing McTN formation. Surprisingly, McTN production was completely abolished by ML-7 treatment (Figures 3a and c) . MCF-10A and PTEN À / À cells treated with 20 mM ML-7 showed only a minimal reduction of pMLC (Supplementary Figure S4 ) consistent with others who have reported that ML-7 does not decrease pMLC. [31] [32] [33] MLCK has also been shown to have a role in disrupting the cortex 34 and have a kinase-independent activity that stimulates the dissociation of actin and myosin. 35 If cortical disruption and dissociation of actin and myosin is inhibited by ML-7, the actin cortex would essentially be 'locked,' a prediction consistent with our observations that ML-7 induces a rounded, smooth shape that suppresses McTNs. Despite their inhibitory effects on myosin, blebbistatin treatment results in a 'loosening,' whereas ML-7 treatment results in a 'tightening' of actin cortex. 30 Our previous studies have shown that the McTNs promote the reattachment of cells to tissue culture substrates and endothelial monolayers. 7, 23, 27 However, when McTNs were induced by actin depolymerization, cell attachment was not significantly increased. 7 Although actin depolymerization can decrease cellular contractility to increase McTNs, it may also impair cytoskeletal functions necessary for firm adhesion. Blebbistatin induced McTNs, but to verify that these induced McTNs maintained functionality, we assessed cell-substratum reattachment. Change in impedance was measured for PTEN À / À and parental cells during initial adhesion (the first hour after initial cell seeding). In the presence of blebbistatin, cells adhered two-fold quicker than that of the control (Figure 3d ; raw data, Supplementary Figure S5) . Conversely, cells plated in ML-7-containing media attached twofold slower and never regained the ability to spread (Figure 3d ; raw data, Supplementary Figure S5 ). Although broadly depolymerizing actin generates McTNs that cannot increase attachment, specifically altering actomyosin contractility can either suppress McTNs (ML-7) or induce McTNs that remain functional for cellsubstratum attachment (blebbistatin).
Activated cofilin is elevated in the suspended PTEN
À / À MECs and regulates McTNs We were able to manipulate cellular contractility, the actin cytoskeleton and McTN production by modulating the function of non-muscle myosin II. Therefore, we examined the phosphorylation status of MLC, but no consistent differences between suspended MCF-10A and PTEN À / À clones were observed (Supplementary Figure S6) . Alternatively, we found that the MCF-10A parental cells maintained a higher level of phosphorylated (inactive) cofilin (Figure 4a ). Densitometry analysis of four separate experiments shows that pCofilin levels only decrease by 20% in MCF-10A cells after detachment. By comparison, pCofilin levels are reduced by 55-75% in PTEN À / À cells, indicating a more robust detachment-induced activation of cofilin in PTEN À / À cells (Figure 4b ). We constructed a non-phosphorylatable mutant cofilin (S3A) that remains active 36 upstream of the IRES-GFP marker and scored GFP-positive transfected cells for McTNs production. There is a significant difference in cofilin phosphorylation and McTN generation between vector control and wild-type (WT) cofilin-expressing cells and between the WT cofilin-and S3A-expressing cells (Figure 4c ). MCF-10A cells were able to highly phosphorylate exogenous WT cofilin and suppress McTNs. Although the S3A mutant did not induce McTNs to the levels observed in PTEN À / À cells, likely due to the fact that it was unable to suppress phosphorylation of endogenous cofilin as the levels of pCofilin remain similar to that of the non-transfected and vector-transfected controls (Figure 4c) , it was able to relieve suppression of McTNs observed in the WT overexpressing cells.
The PTEN À / À cells were similarly able to highly phosphorylate exogenous WT cofilin, which resulted in suppression of McTNs (Figure 4d ). To further confirm that an increase in inactivated cofilin could decrease McTNs production, a cofilin S3E phosphomimic was also constructed for expression in the PTEN À / À cells 36 and able to suppress McTNs (Figure 4d ). Beyond exogenous expression of WT and mutant cofilin, we were able to manipulate endogenous cofilin phosphorylation levels via expression of the cofilin phosphatase, Slingshot-1L (SSH). SSH expression dephosphorylates cofilin (activates), leading to an increase in McTN production ( Figure 4e ). Both the vector control and the catalytically inactive SSH are unable to dephosphorylate cofilin or produce any increase in McTNs (Figure 4e ).
Increased activated cofilin in the PTEN À / À MECs is not due to elevated PI3K or AKT activity The absence of PTEN expression promotes the activation of the PI3K and MAPK pathways, 14 and PTEN À / À cells maintain higher levels of pAKT than parental controls in suspension (Figure 4a ). To determine the importance of the PI3K pathway in the production of McTNs, a small-molecule inhibitor (LY294002) was used to suppress PI3K activity, which was confirmed by a dose-dependent decrease in pAKT in all the three PTEN À / À clones (Figure 5a ). If the increase in PI3K activity or pAKT in the PTEN À / À cells was responsible for the decrease in pCofilin, the pCofilin levels should increase upon LY294002 treatment. However, this was not the case. Despite the presence of the PI3K inhibitor, the pCofilin levels remained much lower in all the three PTEN À / À clones than the MCF-10A controls (Figure 5a ) and addition of LY294002 did not alter McTN production (Figure 5b ). Therefore, PI3K activity and/or pAKT are not responsible for the cofilin activation and increased McTNs in the suspended PTEN À / À cells. In support of this conclusion, the MCF-10A cells with the 'knock-in' PIK3CA mutations in exon 9 or 20, which render PI3K constitutively active, 37 do not exhibit increased McTNs over the MCF-10A cells (Figure 5c ). Additionally, although the clones with the activating PI3K maintain elevated pAKT levels in suspension, their pCofilin levels do not decrease past that of the suspended MCF-10A cells (Figure 5d and e) . Future investigations will be required to determine if PTEN's role as a broad-spectrum protein phosphatase or cytoskeletal docking protein are responsible for this cofilin regulation, but our results establish that PTEN loss activates cofilin without requiring PI3K or Akt activity. PI3K mutation and PTEN loss differentially regulate LIM-kinase1 (LIMK) and SSH LIMK and SSH-1L are known to specifically regulate cofilin phosphorylation. LIMK can be activated through phosphorylation of T508 by downstream kinases in the Rho family, [38] [39] [40] but SSH-1L can be inactivated by phosphorylation (S978). 41, 42 Western blot analysis of PTEN À / À cells reveals an absence of phosphorylated LIMK1 (pLIMK)-T508 and phosphorylated SSH-1L (pSSH-1L)-S978 (Figure 6a) , and there is no difference in pLIMK-T508 and pSSH-1L-S978 levels in attached and detached PTEN À / À cells. Therefore, the phosphorylation states of LIMK and SSH-1L at these sites are likely not responsible for the robust decrease in cofilin phosphorylation in the suspended PTEN À / À cells. This finding lends additional support to our conclusion that the change in pCofilin in the PTEN À / À cells is a PI3K-independent event as SSH-1L has been shown to modulate cofilin through PI3K. 43 In contrast, cells expressing mutant PI3K do maintain higher levels of pLIMK-T508 and pSSH-1L-S978 (Figure 6b) . Therefore, the presence of phosphorylated pLIMK-T508 and pSSH-1L-S978 in the mutant PI3K-expressing cells and the absence of pLIMK-T508 and pSSH-1L-S978 in the PTEN À / À cells provides a mechanistic difference that could account for the different levels of pCofilin observed between these two genotypes. Defining the complete signaling mechanisms by which PTEN loss and PI3K mutation cause this differential regulation of pLIMK-T508 and pSSH-1L-S978 will be an important focus for future studies.
Cofilin activation is directly due to PTEN loss To determine whether the increase in activated cofilin is a direct effect of PTEN loss, we restored PTEN expression in the PTEN À / À cells. When both the PTEN or GFP proteins were expressed in adherent PTEN À / À cells, there was no difference in the pCofilin levels ( Figure 7a) . However, an increase in pCofilin was observed in 
DISCUSSION
According to the cellular tensegrity model, epithelial cells counteract the outward force of microtubules, originating from the microtubule organizing center, through contraction of the cortical actin cytoskeleton. 44 Imbalances in cortical regulation can weaken the actin cortex to allow McTN formation. Cofilin is a ubiquitously expressed actin-binding protein required for the reorganization of actin filaments, and its phopho-regulation has been directly linked to cortical actin integrity where depleted or inactivated cofilin results in elevated actomyosin contractility. 45 Our study demonstrates that suspended MECs devoid of PTEN exhibit an increase in activated cofilin compared with their isogenic PTEN-expressing controls (Figure 4 ), leading to increased McTN formation, and that the phosphorylation state of cofilin serine-3 is sufficient to regulate McTNs (Figures 4c-e) . The low levels of pCofilin in suspended PTEN À / À cells are not due to activation of the PI3K pathway. Although pAKT diminishes in the PTEN À / À cells with increasing doses of the PI3K inhibitor, LY294002, the pCofilin levels remain low and the McTNs counts do not change. Additionally, the PIK3CA cells containing activated PI3K mutations do not exhibit an increased McTN or decreased pCofilin, supporting the conclusion that it is not the PI3K pathway activation that causes increased McTN production and cofilin activation in the PTEN À / À cells. Although in another cell system, growth-factor-induced dephosphorylation of pCofilin was due to PI3K-mediated SSH-1L activation, 43 the dephosphorylation of pCofilin we observe with homozygous deletion of PTEN in detached MECs does not seem to operate via a similar mechanism because both PI3K inhibition with LY294002 and PI3K-activating mutants did not affect cofilin activation. The differences in cell type, ECM attachment state and growth-factor stimulation could explain these apparent differences in signaling mechanism.
The cofilin-regulating molecules LIMK1 and SSH also differ between suspended PTEN À / À and PIK3CA cells. The PTEN À / À cells maintain lower levels of pLIMK-T508 and pSSH-S978, which would both favor reduced pCofilin. In contrast to PTEN À / À cells, the PIK3CA cells exhibit higher levels of pLIMK and pSSH than the PTEN À / À cells, events which would both favor increased pCofilin. Further studies are needed to assess whether LIMK is activated via another mechanism or whether other known cofilin-specific phosphatases (SSH2, SSH3 and chronophin) are more active in the PTEN À / À cells. 46, 47 Nonetheless, differential activation of LIMK, SSH, cofilin and McTNs between the PI3K mutant and PTEN À / À cells defines a series of important mechanistic differences in cytoskeletal signaling between PTEN loss and PI3K activation.
In addition to regulating the PI3K pathway and phosphoinositide production, PTEN may have other catalytic, binding or dephosphorylating properties affecting cofilin activation. As a protein phosphatase, PTEN can dephosphorylate tyrosine-, serineand threonine-phosphorylated peptides, 48 although it is not clear how or if PTEN and cofilin associate. PTEN contains a conserved catalytic domain shared with other protein-tyrosine-phosphatases, flanked by noncatalytic, regulatory sequences (protein-tyrosinephosphatases reviewed in Denu et al. 49 ). In addition to its catalytic domain, PTEN has a potential binding site for PDZ domaincontaining proteins at its C-terminus. 50 PTEN also contains a stretch of sequence, overlaping the catalytic domain, which is similar to a domain within the cytoskeletal proteins tensin and auxilin, suggesting that PTEN may participate in regulating cytoskeletal phosphorylation events. 51 PTEN loss/mutation and the reciprocal oncogenic PIK3CA are common targets of mutation in human cancers, being the second most commonly mutated target next to p53. Although some have shown these mutations to be mutually exclusive, 52 others argue that PTEN loss and PIK3CA are concordant. It is believed that PTEN protein loss and PIK3CA mutations have different functional effects on activation of the PI3K signaling pathway, which could lead to different outcomes. 53, 54 A recent study of 125 patients under the age of 55 with lymph-node-negative invasive BCs treated with adjuvant chemotherapy identified PTEN positivity correlated with an excellent prognosis, whereas the PI3K/AKT/ mTOR pathway had no prognostic value. 55 Another study determined that PTEN loss is strongly associated with both mouse and human basal-like BC , which is among the BC subtypes with the worst prognosis. 56 A third study analyzing gene profiles from 351 stage II BC tumors determined that 86% of tumor samples had PTEN mRNA levels below the median and a signature PTEN loss expression profile, which included 11 (3%) samples with PIK3CA mutation along with the low PTEN mRNA levels. 52 The same group used another set of 295 BC samples for gene profiling and the cases with signature PTEN loss expression profile had significantly worse disease-free survival by Kaplan-Meier survival curves.
Recent clinical studies highlight differences in patient outcomes depending on whether a PTEN loss/mutation or PIK3CA mutation is harbored, and PTEN loss leads to a worse prognosis. 52, 55, 56 In this study, we have observed that dynamic, tubulin-based McTNs increase in MCF-10A PTEN À / À clones compared with their isogenic, parental MCF-10A or the PIK3CA-mutated MCF-10A cells. These results establish novel and important distinctions in the cytoskeletal pathway activation that occur with PTEN loss as compared with PIK3CA activation. Significant differences in the activation state of cofilin, LIMK and SSH were all noted between cells with PTEN loss and those with activation of PI3KCA, which could each contribute to the differential elevation of McTNs in PTEN À / À cells. Data indicate that McTNs regulate adhesive properties of detached cells and can increase the efficiency of CTCs reattachment to metastatic sites. 26, 27 This is consistent with the in vivo finding that CTC adhesion is tubulin-dependent and enhanced by actin depolymerization. 57 Our studies demonstrate that PTEN deletion increases both tumor-cell survival 14 and McTN formation in detached cells. These cellular effects provide two possible explanations for why PTEN loss is thought to specifically increase the risk of hematogenous metastasis in BC. 52 Elucidating the critical mechanisms by which PTEN loss enhances these metastatic risk factors may aid the design of novel therapeutic strategies that reduce metastasis by selectively targeting the survival and reattachment of CTCs. Given the numerous differences in cytoskeletal structure and signaling noted between cells with PTEN loss and PIK3CA activation, our data reveal that the prognostic implications and treatment strategies for these two genotypes may ultimately be very distinct.
MATERIALS AND METHODS

Cell culture
MCF-10A cells were purchased from the American Type Culture Collection (Manassas, VA, USA). The maintenance of the MCF-10A, MCF-10A/ PTEN À / À and MCF-10A/PIK3CA 'knock-in' cell lines has been previously described. 14, 37 Cells were maintained in a 37 1C incubator with 5% CO 2 .
Membrane McTN scoring
Cells were trypsinized and suspended in complete media without phenol red for 30 min. Cells were either counted live as previously described 23 or fixed. Briefly, a 50 1C-prewarmed solution of phosphate-buffered saline paraformaldehyde was added to the suspended cells for a final concentration of 4%. Cells were incubated for 10 min at room temperature. An equal volume of Fluoromount plus CellMask Orange plasma membrane stain (1:10 000, Invitrogen, Carlsbad, CA, USA) and Hoechst 33342 (1:5000, Sigma-Aldrich, St Louis, MO, USA) were added. A portion of the fixed and stained cell solution was transferred to a slide and protected with a coverslip. Single cells were scored blindly for McTNs. Cells with two or more McTNs extending greater than the radius of the cell body were scored as positive.
Plasmids and transfections
Cofilin, S3A and S3E were PCR amplified using the following primers and ligated into the XhoI/EcoRI sites of the pIRES2-AcGFP1 plasmid (Clontech, Mountain View, CA, USA). Sense primers: (WT) 5 
Immunofluorescence
Cells were fixed in suspension with 0.3% glutaraldehyde in 80 mM pipes, pH 6.8, 1 mM MgCl 2 , 5mM EGTA and 0.5% NP40 for 20 min at room temperature then centrifuged (300 r.p.m., 5 min) on to poly-L-lysine (SigmaAldrich)-coated coverslips. After washing with phosphate-buffered saline, cells were incubated with 10 mg/ml NaBH 4 for 7 min, washed with phosphate-buffered saline and then incubated with 10 mg/ml bovine serum albumin and 0.1% Tween 20 in phosphate-buffered saline prior to antibody staining. Microtubules were stained indirectly using an antia-tubulin (DM1A, 1:1000; eBioscience, San Diego, CA, USA) followed by AlexaFluor568-or AlexaFluor488-conjugated secondary antibody (1:1000; Invitrogen). Hoechst 33342 (1:5000; Sigma-Aldrich) was added during secondary antibody incubation. Z-stacks were obtained using an Olympus FV1000 confocal microscope (Olympus, Center Valley, PA, USA). Stacks were imaged as maximum intensity projections using ImageJ (NIH, Bethesda, MD, USA).
Cell association assay
The same PTEN À / À clone was plated in duplicate, one stained with CellMask Orange and the other transfected with GFP-mem. Cells were trypsinized, mixed in a single well and allowed to associate. Live cell images were captured using an Olympus IX81 inverted microscope. Threedimensional surface rendering was done using the Volocity software (ImproVision Inc., Waltham, MA, USA).
Attachment assay
The impedance assay used an xCelligence RTCA SP real-time cell-sensing device (Roche Applied Science, Indianapolis, IN, USA) to assess attachment. 27 Impedance values were normalized to the parental MCF-10A control line for each time point. Test cell lines were represented as the fold change of the control cell line attachment.
Western blot analysis
Western blots were performed as previously described.
14 Primary antibodies for PTEN, pAKT (S473), AKT, phosphorylated extracellular signal-regulated kinase 1/2 (pERK1/2), ERK1/2, pCofilin (Ser3) and cofilin were purchased from Cell Signaling (Danvers, MA, USA); a second cofilin antibody recognizing the C-terminal end, LIMK and pLIMK was purchased from Abcam (Cambridge, MA, USA); SSH and pSSH were purchased from ECM Biosciences (Versailles, KY, USA); and anti-GFP was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). All the antibodies were used at the manufacturer's recommended dilutions. Densitometry was performed using ImageJ.
Adenoviral infection Equal numbers of PTEN
À / À cells were infected daily for 2 days with either a PTEN or GFP control adenovirus (Vector Biolabs, Philadelphia, PA, USA). Cell lysates were harvested while the cells were attached or after 1-h suspension. Lysates were analyzed by western blotting. Duplicate PTEN-or GFP-infected cells, both attached and suspended, were fixed, stained and blindly scored for McTN production.
Statistical analysis
Significance was measured by t-test (Excel, Microsoft, Redmond, WA, USA). 
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